1. Shacham Y, Gal-Oz A, Leshem-Rubinow E, et al. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous intervention: incidence, risk factors, and outcomes. Int J Cardiol 2014; 177: 578-80.
2.
Pruc M, Kubica J, Banach M, et al. Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: a meta-analysis of 90 studies including 45 990 patients. Kardiol Pol 2024; 82: 276-84.
3.
Pruc M, Peacock FW, Rafique Z, et al. The prognostic role of platelet-to-lymphocyte ratio in acute coronary syndromes: a systematic review and meta-analysis. J Clin Med 2023; 12: 6903.
4.
Pruc M, Kubica J, Banach M, et al. Prognostic value of the monocyte-to-high-density lipoprotein-cholesterol ratio in acute coronary syndrome patients: a systematic review and meta-analysis. Kardiol Pol 2025; 83: 52-61.
5.
Zhang H, Hu L, Li Q, et al. Prognostic value of red cell distribution width in patients with non-ST elevation myocardial infarction undergoing percutaneous coronary intervention. Medicine (Baltimore) 2024; 103: e37521.
6.
Chen L, Liu P, Feng Z, et al. Association of red blood cell distribution width with mortality risk in patients with coronary artery disease undergoing PCI: a systematic review and meta-analysis. J Soc Cardiovasc Angiogr Interv 2024; 3: 100456.
7.
Gaggini M, Minichilli F, Gorini F, et al. FIB-4 index and neutrophil-to-lymphocyte ratio as death predictors in coronary artery disease patients. Biomedicines 2023; 11: 76.
8.
Cordero A, Escribano D, Quintanilla MA, et al. Prognostic value of the fibrosis-4 index in patients with acute coronary syndrome. J Clin Med 2023; 12: 1983.
9.
Kidney Disease: Improving Global Outcomes (KDIGO). Clinical practice guideline for acute kidney injury. Section 4: contrast-induced AKI. Kidney Int Suppl 2012; 2: 69-88.
10.
Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37: 267-315.
11.
Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619.
12.
Siudak Z, Hawranek M, Kleczyński P, et al. Interventional cardiology in Poland in 2022. Annual summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society (AISN PTK) and Jagiellonian University Medical College. Adv Interv Cardiol 2023; 19: 82-5.
13.
Siudak Z, Grygier M, Tomaniak M, et al. Interventional cardiology in Poland in 2023. Annual summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society (AISN PTK) and Jagiellonian University Medical College. Adv Interv Cardiol 2024; 20: 379-81.
14.
Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-5.
15.
Silvain J, Nguyen LS, Spagnoli V, et al. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2018; 104: 767-72.
16.
Lang J, Patyna S, Büttner S, et al. Incidence, risk factors and prognostic impact of acute kidney injury after coronary angiography and intervention in kidney transplant recipients: a single-center retrospective analysis. Adv Interv Cardiol 2020; 16: 58-64.
17.
Chong E, Poh KK, Liang S, et al. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol 2010; 23: 451-9.
18.
Rakowski T, Dziewierz A, Węgiel M, et al. Risk factors of contrast-induced nephropathy in patients with acute coronary syndrome. Kardiol Pol 2022; 80: 760-4.
19.
Wrona P, Sawczyńska K, Wróbel D, et al. Risk factors of acute kidney injury during hospitalization in acute ischaemic stroke patients undergoing mechanical thrombectomy. Adv Interv Cardiol 2024; 20: 89-94.
20.
McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-75.
21.
Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005; 67: 706-13.
22.
Sreenivasan J, Zhuo M, Khan MS, et al. Anemia (hemoglobin ≤ 13 g/dL) as a risk factor for contrast-induced acute kidney injury following coronary angiography. Am J Cardiol 2018; 122: 961-5.
23.
Cordero A, Escribano D, Quintanilla MA, et al. Prognostic value of liver fibrosis assessed by the FIB-4 index in patients with acute coronary syndrome. Rev Esp Cardiol 2023; 76: 618-25.
24.
Song J, Liu Y, Chen J, et al. Fibrosis-4 stage of liver fibrosis predicts cardiovascular outcomes in acute coronary syndrome patients with and without type 2 diabetes mellitus. Diabetes Res Clin Pract 2023; 195: 110206.
25.
He HM, He C, You ZB, et al. Non-invasive liver fibrosis scores are associated with contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention. Angiology 2023; 74: 333-43.
26.
Liu HH, Cao YX, Jin JL, et al. Liver fibrosis scoring systems as novel tools for predicting cardiovascular outcomes in patients following elective percutaneous coronary intervention. J Am Heart Assoc 2021; 10: e018869.
